An AI-powered wearable sensor can detect changes in heart failure patients before an actual crisis occurs, according to new findings published in Circulation: Heart Failure.
The diabetes drug dulaglutide—sold commercially as Trulicity—has received an expanded indication for the reduction of major adverse cardiovascular events in adults with type 2 diabetes and established CVD or CV risk factors.
Such occurrences are relatively rare in radiology, but even one case of patient harm is too many, experts argue, underlining the importance of staying on top of this issue.
Researchers from Kaiser Permanente Northern California implemented the reporting system at their institution, sharing some of their "reservations" in Radiology.
Presidential hopeful Bernie Sanders has refused to release further medical information about an MI he suffered last October, leaving much of the public with questions about his heart health.
CMS and the Office of the National Coordinator for Health Information Technology (ONC) have issued their strategy to reduce the burdens clinicians face when it comes to using EHRs.
As AI continues to make a profound impact on the medical imaging industry, the FDA is hosting a two-day public workshop to discuss the benefits and risks of this powerful technology.
A new “super nurse” designed using AI technology, advanced sensors and cameras is now collecting patient data at Israel’s Tel Aviv Sourasky Medical Center.
